Compassionate Use of Evinacumab

Clinical trial NCT06500598 · APPROVED_FOR_MARKETING

Trial details

NCT number: NCT06500598
Sponsor: Regeneron Pharmaceuticals
Status: APPROVED_FOR_MARKETING
Study type: EXPANDED_ACCESS

Pediatric Homozygous Familial Hypercholesterolemia (HoFH)Severe Hypertriglyceridemia (HTG)Dysbetalipoproteinemia (DBL)

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.